Search

everythinglearnresearchcommunity

for

Search:↓

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Microneedling and oral tranexamic acid both improve facial melasma, but microneedling shows more sustained benefits.

Topical rapamycin may effectively treat fibrous papules on the face.

Current treatments for recurrent ischemic priapism are not well-defined and need more research.

Fremanezumab effectively reduces migraines and improves quality of life with mild side effects.

Dihydrotestosterone might cause migraines, and finasteride could help reduce them.

Mimosine dipeptides are promising for treating hyperpigmentation and inflammation.

Both treatments work, but Minoxidil 0.5% MMP® is better for certain scalp areas and less advanced hair loss.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.

Tranexamic acid effectively reduced swelling episodes in a girl with a rare form of hereditary angioneurotic edema.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

Cystatin M/E strongly inhibits cathepsin V and cathepsin L, important for skin formation.

Microinfusion of methotrexate can help treat frontal fibrosing alopecia.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Merremia peltata leaf extract, particularly the bufotalinin compound, shows potential for treating hair loss.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

The report expanded knowledge of MBTPS1-related disorders by identifying new symptoms.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Recognizing specific markers is crucial for correctly diagnosing and treating rare multifocal MPTT in males.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Intralesional methotrexate effectively treats patchy alopecia areata by reducing inflammation.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.